Study shows no significant difference in herpes zoster risk between psoriasis patients receiving systemic therapy and those not receiving systemic therapy.
Dermatology Times – Dermatology
Tag Archives: rates
Why MS relapse rates are underreported: What health execs should know
Two patient survey studies sponsored by Mallinckrodt and Harris Poll have revealing findings about patient-reported multiple sclerosis rates.
Managed Healthcare Executive – Health Management
Three reasons why maternal mortality rates are rising
Lymph-node dissection increases rates of regional disease control
Lymph-node dissection is not associated with increased melanoma survival. Surgery may be best option to decrease risk for recurrence. A positive sentinel node does not automatically lead to complete dissection
Dermatology Times – Dermatology
Analyst: Payer hurdles hit dispense rates on Sanofi and Regeneron’s eczema blockbuster-to-be Dupixent – FiercePharma
FiercePharma |
Analyst: Payer hurdles hit dispense rates on Sanofi and Regeneron's eczema blockbuster-to-be Dupixent
FiercePharma Analyst: Payer hurdles hit dispense rates on Sanofi and Regeneron's eczema blockbuster-to-be Dupixent. by Tracy Staton |. Jul 14, 2017 11:18am. Dupixent package. Sanofi and Regeneron negotiated with payers early on to come up with pricing both sides … |